Malley Thomas
SEC insider (Form 3/4/5 filer). CIK 0001403322. Director at Kura Oncology, Inc. (KURA) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in LONDON.
Companies Malley Thomas has filed insider reports for
- Kura Oncology, Inc. (KURA): Director
- Kiniksa Pharmaceuticals International, plc (KNSA): Director
Malley Thomas
CIK: 0001403322
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Jun 4, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
35K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.8K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
12.2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2K shares- - Mar 18, 2026KURA
Kura Oncology, Inc.
ExerciseDirect10K shares at avg. $3.12$31K - Aug 14, 2025KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect78.2K shares at avg. $33.09$2.6M - Aug 14, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect18.8K shares at avg. $15.47$290K - Aug 14, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect33.2K shares at avg. $14.33$476K - Aug 14, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect26.2K shares at avg. $15.19$399K - Aug 13, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect20.1K shares at avg. $10.36$209K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award Option to purchase common stock | 35,000 | - | - | Direct |
| May 29, 2026 |  KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,799 | - | $0 | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 12,158 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,026 | - | - | Direct |
| Mar 18, 2026 | KURA Kura Oncology, Inc. | Exercise | 10,000 | $3.12 | $31,200 | Direct |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 78,233 | $33.09 | $2,588,730 | Direct |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 18,760 | $15.47 | $290,217 | Direct |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 33,237 | $14.33 | $476,286 | Direct |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 26,236 | $15.19 | $398,525 | Direct |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 20,129 | $10.36 | $208,536 | Direct |
1-10 of 19 transactions